Health Management

A new study found that distinguishing between population health and community health strategies can help health organizations define clear goals and earmark the right resources to accomplish them.

A National Lipid Association survey has interesting findings on the prescription approval process for PCSK9 inhibitors.

Although drug spend is increasing for inflammatory conditions, diabetes, and oncology, there are some promising developments in the pipeline.

Alternatives to opioids programs emerge as viable tools to mitigate the crisis.

AHIP 2017: SummaCare exec shares their best practices for patient care outreach.

A new RAND analysis of retail clinics finds they could be increasing healthcare costs.

Digital health pioneer Eric Topol talks about plans for a four-year precision medicine study at AHIP 2017.

New research shows hypertension, diabetes influence survival of ovarian cancer patients in different ways.

Alcohol consumption is known to be a risk factor for breast cancer based on studies predominantly done in white women. Now, a University of North Carolina Lineberger Comprehensive Cancer Center study has found the same risk exists for black women.

It has been an exciting time at the Myeloma Institute at the University of Arkansas for Medical Sciences, on all fronts, namely, embarking on research that could play an important role in the development of preventative and curative strategies for multiple myeloma in the future.

Here are three things to consider when developing a population health management team at your organization.

Key socioeconomic data that will help you care for your most vulnerable populations.

A new report reveals how personalized medicine can make patients healthier while lowering costs.

Find out how the American College of Physicians says population health data can decrease opioid addiction and abuse.

Here are four things MCOs should know about a new study focusing on young patients with diabetes.

Humana’s goal is to improve the health of the communities it serves 20% by the year 2020. Find out how it is reaching this goal.

The Medical College of Wisconsin’s multiple myeloma program is robust and growing.

A new study provides new insights into the epidemiology of breast cancer among the most prominent Asian-American ethnic groups in California.

A new study from researchers from the Minneapolis VA Health Care System has interesting findings.

As new scientific advancements occur at the genetic and protein levels, more strategies have been developed to identify and combat multiple myeloma.

Here's how five health plans are successfully approaching palliative care.

Diabetes accounts for one out of every 10 American healthcare dollars spent, but new national programs are helping address this issue.

Study: PCSK9 inhibitors are being rejected by insurers at very high rates even in high-risk patients like those with familial hypercholesterolemia.

A Cleveland Clinic study examines the mortality burden of modifiable behavioral risk factors such as obesity, diabetes, tobacco use, high blood pressure and high cholesterol.

New findings reveal this genetic test to assess breast cancer risk could be more effective than others.

A new Commonwealth Fund survey on how Medicaid changes could affect this population, has experts weighing in on ways to resolve the healthcare disconnect.

Nationwide Children’s Hospital sees dramatic drop in ED visits and inpatient admissions for epilepsy patients with collaborative quality improvement project.

A new outcomes study shows that the PCSK9 inhibitor Repatha significantly reduced the risk of hard major adverse cardiovascular events in high-risk patients by 20%.

CVS, Novo Nordisk launch a prescription savings program to help patients afford essential medications.

One thing that is unlikely to change under the new Administration is the goal of reducing the cost of healthcare through various alternative payment initiatives. Here’s how that will affect oncology.